Latest

Walmart’s market capitalization surpassed $1 trillion on Tuesday, making it the first traditional retailer to reach this milestone and joining the elite club previously dominated by tech giants. The Arkansas-based retail giant’s stock price has more than doubled over the past two years, outperforming the S&P

``` A routine update in the field of artificial intelligence has triggered a sharp shock in the legal software sector. Anthropic’s release last Friday of its Claude Cowork AI agent's legal plugin sparked a collective plunge in related stocks on Tuesday, with several shares dropping more than 15%

The launch of new automation tools by AI startup Anthropic on Tuesday triggered panic selling in software stocks, causing all three major U.S. stock indexes to retreat. In intraday trading, the S&P 500 fell more than 1.6%, the Nasdaq Composite dropped around 2.4%, the Nasdaq

Nvidia CEO Jensen Huang denies rumors of tensions with OpenAI, confirms participation in OpenAI’s next round of financing and calls it “the largest private fundraising in history.” On Tuesday, February 3, Huang stated in an interview with CNBC’s Jim Cramer that the company’s investment plan in OpenAI

``` Bitcoin fell to its lowest point since Trump returned to the White House on Tuesday, erasing all the gains the iconic digital asset had accumulated since US President Trump’s election. Although the Trump administration has displayed a friendly stance toward cryptocurrencies and institutional adoption has surged, Bitcoin has dropped

``` On February 3, Pfizer’s 2025 full-year financial report showed the company demonstrating strong operational resilience during its strategic transformation phase. According to the financial report, total full-year revenue was $62.6 billion; excluding COVID-related products, its core business portfolio achieved 6% operating growth. Adjusted earnings per share reached $3.

On February 3, Merck released its financial results for the fourth quarter and full year of 2025. Driven by continued growth of Keytruda, increased contributions from new products such as Winrevair and Capvaxive, and steady performance in animal health, the company achieved full-year sales of $65 billion, up 1% year-on-year.